Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by noodleyon Oct 22, 2010 5:26pm
277 Views
Post# 17601093

RE: RE: why did they sell @ .47 on 5/17/2010 ?

RE: RE: why did they sell @ .47 on 5/17/2010 ?royally....bang on with your  comments re 19 may.  mike needs to move on - take up a sport or maybe revisit the math on the myian vs gregorian calander.  everybody learned from the black tuesday waterfall.  confidence here is lower than obama's poll numbers and expectations are rock bottom.   that's where they should be. people know this dog won't hunt ill the new year.  meantime.... since sept sss has been on a rebuilding kick and i suspect the monday meeting will be just another bootprint.  if they have the goods....47 will happen again.  and if it does...it'll be very quick. 
Bullboard Posts